Clinical trials
Multiple Myeloma trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| European Myeloma Network B.V. | 2 |
| Celgene | 1 |
| Janssen Research & Development, LLC | 1 |
| Janssen-Cilag International NV | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Oncopeptides AB | 1 |
| Shanghai Henlius Biotech | 1 |
| Stichting European Myeloma Network | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 13 |
| Bone Marrow Neoplasms | 1 |
| Disease Progression | 1 |
| Leukemia | 1 |
| Leukemia, Plasma Cell | 1 |
| Lymphoma, B-Cell | 1 |
| Recurrence | 1 |
| Smoldering Multiple Myeloma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.